文献速递流行病学与生物统计临床试验与 GCP

早期宫颈癌微创根治性子宫切除术后生存分析

Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
PubMed 文献 · N Engl J Med · 2018-10-31

该研究基于美国国家癌症数据库2010-2013年数据,纳入2461例IA2或IB1期宫颈癌根治性子宫切除术患者,采用倾向评分加权分析。中位随访45个月,微创手术组4年死亡率为9.1%,开腹组为5.3%(HR 1.65;95%CI 1.22-2.22;P=0.002)。中断时间序列分析显示,微创手术推广后4年相对生存率每年下降0.8%(95%CI 0.3-1.4;P=0.01)。结论认为微创根治性子宫切除术与更短的总生存期相关。

要点

  • 早期宫颈癌微创根治性子宫切除术与开腹手术相比,总生存期更短。
  • 微创组4年死亡率为9.1%,开腹组为5.3%,HR 1.65(95%CI 1.22-2.22)。
  • 微创手术推广后4年相对生存率每年下降0.8%(95%CI 0.3-1.4)。

核心结论

  • 在IA2或IB1期宫颈癌女性中,微创根治性子宫切除术与开腹手术相比与更短的总生存期相关。

研究设计与样本

  • 队列研究纳入2010-2013年美国Commission on Cancer认证医院中因IA2或IB1期宫颈癌行根治性子宫切除术的女性,采用逆概率处理倾向评分加权。
  • 中断时间序列分析纳入2000-2010年Surveillance, Epidemiology, and End Results项目数据库中因宫颈癌行根治性子宫切除术的女性。

主要发现

  • 主要分析中2461例女性有1225例(49.8%)接受微创手术。
  • 中位随访45个月,微创手术组4年死亡率为9.1%,开腹手术组为5.3%(HR 1.65;95%CI 1.22-2.22;P=0.002)。
  • 2000-2006年期间,根治性子宫切除术后的4年相对生存率保持稳定(年度百分比变化0.3%;95%CI -0.1至0.6)。
  • 2006年后微创手术的采用与4年相对生存率每年下降0.8%(95%CI 0.3至1.4)相吻合(趋势变化P=0.01)。

临床怎么用

  • 对于IA2或IB1期宫颈癌患者,选择根治性子宫切除术式时需权衡微创手术与开腹手术对生存的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive surgery was adopted as an alternative to laparotomy (open surgery) for radical hysterectomy in patients with early-stage cervical cancer before high-quality evidence regarding its effect on survival was available. We sought to determine the effect of minimally invasive surgery on all-cause mortality among women undergoing radical hysterectomy for cervical cancer. METHODS: We performed a cohort study involving women who underwent radical hysterectomy for stage IA2 or IB1 cervical cancer during the 2010-2013 period at Commission on Cancer-accredited hospitals in the United States. The study used inverse probability of treatment propensity-score weighting. We also conducted an interrupted time-series analysis involving women who underwent radical hysterectomy for cervical cancer during the 2000-2010 period, using the Surveillance, Epidemiology, and End Results program database. RESULTS: In the primary analysis, 1225 of 2461 women (49.8%) underwent minimally invasive surgery. Women treated with minimally invasive surgery were more often white, privately insured, and from ZIP Codes with higher socioeconomic status, had smaller, lower-grade tumors, and were more likely to have received a diagnosis later in the study period than women who underwent open surgery. Over a median follow-up of 45 months, the 4-year mortality was 9.1% among women who underwent minimally invasive surgery and 5.3% among those who underwent open surgery (hazard ratio, 1.65; 95% confidence interval [CI], 1.22 to 2.22; P=0.002 by the log-rank test). Before the adoption of minimally invasive radical hysterectomy (i.e., in the 2000-2006 period), the 4-year relative survival rate among women who underwent radical hysterectomy for cervical cancer remained stable (annual percentage change, 0.3%; 95% CI, -0.1 to 0.6). The adoption of minimally invasive surgery coincided with a decline in the 4-year relative survival rate of 0.8% (95% CI, 0.3 to 1.4) per year after 2006 (P=0.01 for change of trend). CONCLUSIONS: In an epidemiologic study, minimally invasive radical hysterectomy was associated with shorter overall survival than open surgery among women with stage IA2 or IB1 cervical carcinoma. (Funded by the National Cancer Institute and others.).

来源:N Engl J Med,查看原文。版权归原作者所有。

引用

  1. Melamed A, Margul DJ, Chen L, et al. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med. 2018. PMID: 30379613. doi:10.1056/NEJMoa1804923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。